国际调查:免疫性血小板减少症患者的幽门螺杆菌检测实践
该国际调查向39个国家的血液科医生发放17项情景问卷,共186人完成。来自亚洲和中东的37名受访者中51.4%总是检测。检测决策受国家、来源地和胃肠道症状影响,根除方案以质子泵抑制剂+克拉霉素+阿莫西林14天为主。
要点
- 亚洲和中东受访者中51.4%总是检测,理由为局部高患病率和血小板获益。
- 来自亚洲的患者(80%)和有胃肠道症状者(72%)更常被检测。
核心结论
- ITP患者幽门螺杆菌检测在亚洲及来自亚洲的患者中最常见。
- 检测和治疗实践在不同地理区域存在差异。
研究设计与样本
- 面向全球血液科医生的17项情景问卷国际调查,使用滚雪球抽样和血小板疾病支持协会医生联系名单。
- 共186名来自39个国家的受访者完成问卷,滚雪球样本应答率为53.6%。
主要发现
- 来自亚洲和中东的37名受访者中,51.4%(n=19)总是检测,理由为局部高患病率和治疗对血小板计数的感知获益。
- 受访者更可能检测来自亚洲的患者(145/177,80%)和有伴随胃肠道症状的患者(133/183,72%)。
- 根除治疗中,71/118(60.2%)的受访者使用质子泵抑制剂、克拉霉素和阿莫西林联合治疗14天。
关键数值与推荐
- 亚洲和中东受访者中总是检测者占51.4%(n=19)。
- 来自亚洲的患者被检测的比例为80%(145/177),有胃肠道症状者为72%(133/183)。
- 根除方案中质子泵抑制剂+克拉霉素+阿莫西林14天者占60.2%(71/118)。
临床怎么用
- 临床检测幽门螺杆菌的决策需考虑患者来源地区(尤其亚洲)和有无胃肠道症状。
- 根除治疗可参考常用方案:质子泵抑制剂+克拉霉素+阿莫西林14天。
局限性
- 调查基于情景问卷和滚雪球抽样,应答率53.6%,可能存在选择偏倚。
- 数据为描述性分析,未报告检测与治疗对临床结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Essentials When to test and treat H pylori among patients with ITP is controversial. We report the results of an international survey administered to physicians with experience treating ITP across 39 countries. The decision to test for H pylori was influenced by country, country of origin, and concomitant gastrointestinal symptoms. Testing and treating for H pylori among patients with ITP varied across geographic regions. ABSTRACT: Background Investigations for patients suspected of immune thrombocytopenia (ITP) lack standardization. A controversial issue is whether such patients should be tested for Helicobacter pylori, a known cause of secondary ITP. Objectives This Scientific and Standardization Committee Communication reports the results of an international survey to describe patterns of practice with respect to screening and treatment of H pylori among patients with ITP. Patients/Methods A 17-item scenario-based questionnaire was delivered to hematologists in countries across the world. The questionnaire was pilot tested before use. We used snowball sampling and a contact list of physicians from the Platelet Disorders Support Association to identify survey respondents. Data were analyzed descriptively. Results A total of 186 respondents from 39 countries completed the survey. Response rate from the snowball sample was 53.6%. Twenty-nine percent (n = 55) of respondents always tested ITP patients for H pylori, and 53% (n = 98) sometimes tested. Of the 37 respondents from Asia and the Middle East, 51.4% (n = 19) always tested for H pylori for the stated reasons of high local prevalence and perceived benefit of treatment on platelet count levels. Respondents were more likely to test patients who were from Asia (145/177, 80%) and who had concomitant gastrointestinal symptoms (133/183, 72%). For eradication therapy, 71 of 118 (60.2%) respondents used the combination of a proton pump inhibitor, clarithromycin, and amoxicillin for 14 days. Conclusions This international survey showed that testing for H pylori was most common in Asia and in patients from Asia. Testing and treating practices varied across geographic regions.
引用
- Vishnu P, Duncan J, Connell N, et al. International survey on Helicobacter pylori testing in patients with immune thrombocytopenia: Communication of the platelet immunology scientific and standardization committee. J Thromb Haemost. 2021. PMID: 33070448. doi:10.1111/jth.15136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。